Opioid lawsuits: Sackler family agree final $6bn civil settlement with US states
BMJ 2022; 376 doi: https://doi.org/10.1136/bmj.o616 (Published 09 March 2022) Cite this as: BMJ 2022;376:o616- Owen Dyer
- Montreal
The Sackler family, billionaire owners of Purdue Pharma who are widely blamed for helping to spark the US opioid epidemic with dishonest marketing of their opioid OxyContin, have agreed a final settlement with US states seeking damages, after raising their offer from $4.3bn to $6bn.1
The deal brings on board nine states who had rejected the previous offer, and shields the family from further litigation, though not from any criminal charges. The money will fund addiction treatments and the purchase of the overdose drug naloxone. There will also be compensation of up to $48 000 for affected people.
The Sacklers will be required to attend a further court hearing where victims will give testimony on their experiences. …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.